Abstract
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyReferences
- Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.Am J Cardiol. 1998; 81: 18B-25B
- Coronary heart disease in high-risk populations.Eur Heart J. 1990; 11: 462-471
National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. The Evidence Report. Bethesda, Md: National Institutes of Health; 1968.
- Familial dyslipidaemic hypertension and other multiple metabolic syndromes.Ann Med. 1992; 24: 469-475
- Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis.Diabetologia. 1991; 34: 457-462
- Impaired glucose tolerance.in: LeRoith D. Taylor S.I. Olefsky J.M. Diabetes Mellitus. A Fundamental and Clinical Text. Lippincott-Raven Publishers, Philadelphia1996: 467-474
- Quantification of coronary artery calcium using ultrafast computed tomography.J Am Coll Cardiol. 1990; 15: 827-832
- Pathophysiology of insulin resistance in human disease.Physiol Rev. 1995; 75: 473-486
- Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease.Diabetes Care. 1991; 14: 173-194
- Effects of varying carbohydrate content of diet in patients with noninsulin-dependent diabetes mellitus.JAMA. 1994; 271: 1421-1428
- Characterization of the insulin resistance of aging.J Clin Invest. 1983; 71: 1581-1587
- Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease.Endocr Res. 1996; 22: 701-708
- Insulin resistance and the polycystic ovary syndrome.Endocr Rev. 1997; 18: 774-800
- Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridemia in man.Diabetologia. 1976; 12: 563-571
- Hyperinsulinaemia and hypertriglyceridaemia.J Intern Med Suppl. 1994; 736: 23-26
- The insulin resistance-dyslipidemic syndrome of visceral obesity.Obes Res. 1998; 6: 8S-17S
- Abnormal metabolism of free fatty acids in hypertriglyceridaemic men.J Intern Med. 1998; 243: 265-274
- Influence of body fat distribution on free fatty acid metabolism in obesity.J Clin Invest. 1989; 83: 1168-1173
- Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.J Clin Invest. 1986; 78: 1287-1295
- Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.J Lipid Res. 1985; 26: 556-565
- Small, dense low-density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes.Curr Opin Lipidol. 1996; 7: 167-171
- A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects.Diabetologia. 1995; 38: 1328-1336
- Isolated low HDL cholesterol. An insulin-resistance state.Diabetes. 1994; 43: 411-417
- Insulin resistance in hypertension.Am J Med Sci. 1993; 306: 345-347
- Insulin resistance and hypertension.Mol Cell Endocrinol. 1990; 74: C87-C89
- Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system.N Engl J Med. 1996; 334: 374-381
- Hypertension, dyslipidemia, and insulin resistance.Curr Opin Lipidol. 1996; 7: 241-253
- Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension.JAMA. 1988; 259: 3579-3586
- Metabolic disturbances in hypertension: results from the population study “men born in 1913.”.J Intern Med. 1992; 232: 389-395
- Prediction of coronary heart disease using risk factor categories.Circulation. 1998; 97: 1837-1847
- Lipoproteins and the haemostatic system in atherothrombotic disorders.Baillieres Clin Haematol. 1994; 7: 713-732
- Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia.Arterioscler Thromb Vasc Biol. 1998; 18: 20-26
- Hypertriglyceridemia, but not hypercholesterolemia, is associated with the alterations of fibrinolytic system.Horm Metab Res. 1996; 28: 603-606
- Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1.J Atheroscler Thromb. 1995; 2: S41-S46
- Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity.Diabetologia. 1993; 36: 817-825
- Investigations into the haemorheological significance of postprandial and fasting hypertriglyceridaemia.Eur J Clin Invest. 1993; 23: 270-276
- The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.Metabolism. 1993; 42: 945-949
- Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity.Arterioscler Thromb. 1994; 14: 1264-1271
- Hypofibrinolysis and the insulin resistance syndrome.Int J Obes Relat Metab Disord. 1995; 19: S11-S15
- Insulin resistance syndrome and fibrinolytic activity.Int J Epidemiol. 1996; 25: 291-299
- PAI-1, obesity, insulin resistance and risk of cardiovascular events.Thromb Haemost. 1997; 78: 656-660
- Weight loss reduces abdominal fat and improves insulin action in middle-aged and older men with impaired glucose tolerance.Metabolism. 1995; 44: 1502-1508
- Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity.Hypertension. 1996; 27: 1180-1186
- The benefits of modest weight loss in type II diabetes.Int J Obes Relat Metab Disord. 1997; 21: S10-S13
- Diet and exercise in the treatment of obesity.Arch Intern Med. 1998; 158: 2477-2483
- Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men.Metabolism. 1998; 47: 1075-1082
- The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.Diabetes Care. 1998; 21: 687-694
- Changes in insulin sensitivity, glucose effectiveness, and β-cell function in regularly exercising subjects.Metabolism. 1995; 44: 1259-1263
- Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men.J Appl Physiol. 1996; 81: 318-325
- Exercise training reverses insulin resistance in muscle by enhanced recruitment of GLUT-4 to the cell surface.Am J Physiol. 1997; 272: E864-E869
- Improvement of insulin sensitivity by short-term exercise training in hypertensive African American women.Hypertension. 1997; 30: 1549-1553
- Glucose tolerance is improved after low- and high-intensity exercise in middle-age men and women.Can J Appl Physiol. 1998; 23: 583-593
- Exercise, glucose transport, and insulin sensitivity.Annu Rev Med. 1998; 49: 235-261
- Intensity and amount of physical activity in relation to insulin sensitivity.JAMA. 1998; 279: 669-674
- Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects.N Engl J Med. 1996; 335: 1357-1362
- Thiazolidinediones.Endocrinol Metab Clin North Am. 1997; 26: 553-573
- Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone.Ann Intern Med. 1998; 129: 36-38
- Troglitazone-induced hepatic failure leading to liver transplantation.Ann Intern Med. 1998; 129: 38-41
- Fatal hepatotoxicity associated with troglitazone.Ann Intern Med. 1998; 129: 1080
- Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study.Am J Cardiol. 1989; 63: 42H-47H
- Reduction of mortality in the Stockholm ischaemic heart disease secondary prevention study to combined treatment with clofibrate and nicotinic acid.Acta Med Scand. 1988; 223: 405-418
Kaplinsky E. The Bezabifrate Infarction Prevention Study. Preliminary results presented at the annual meeting of the European Society of Cardiology, Vienna, August 1998.
- Management of primary mixed hyperlipidemia with lovastatin.Arch Intern Med. 1990; 150: 1313-1319